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Labeling of proteins and peptides with stable heavy isotopes (deuterium, carbon-13, nitrogen-15,
and oxygen-18) is widely used in quantitative proteomics. These are either incorporated meta-
bolically in cells and small organisms, or postmetabolically in proteins and peptides by chemical
or enzymatic reactions. Only upon measurement with mass spectrometers holding sufficient
resolution, light, and heavy labeled peptide ions or reporter peptide fragment ions segregate and
their intensity values are subsequently used for quantification. Targeted use of these labels or
mass tags further leads to specific monitoring of diverse aspects of dynamic proteomes. In this
review article, commonly used isotope labeling strategies are described, both for quantitative
differential protein profiling and for targeted analysis of protein modifications.
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1 Introduction
Stable isotopes in combination with MS have been used for
several decades by clinical chemists and pharmacists as
quantification tools to measure concentrations of natural
compounds [1]. Today, similar approaches have found broad
application in contemporary proteome research. Depending
on the introduced isotope spacer and the resolving power of
the mass spectrometer, isotope envelopes of labeled peptides
can be partly or fully resolved and are used for their quanti-
fication. To find proteins or peptides with significantly dif-
ferent concentrations in sampled proteomes, different stable
heavy isotope labeling techniques are now fully exploited.
Depending on the sample’s origin, isotope labeling may be
performed on different levels (organism, cell, protein, or
peptide) and on different reactive groups. Furthermore,
multiplexed labeling increasing sample throughput and
allowing temporal and spatial proteomics became possible.
We here discuss commonly used isotope labeling tech-
niques in contemporary proteome research, focus on their
potential and shortcomings, and illustrate how isotope
labeling can be used for targeted analysis of specific features
of dynamic proteomes.
2 Metabolic labeling techniques for
proteomics
2.1 Labeling of cell cultures
Metabolic labeling of cells with stable isotopes for quantita-
tive contemporary proteomics was first described by the lab
of Brian Chait in 1999 [2]. His group grew baker’s yeast in
medium that was for more than 96% enriched in nitrogen-
15. The levels of selected, rather high abundant proteins
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from two yeast strains – a wild type strain and one over-
expressing the G1 cyclin CLN2 – were compared, after
growing these in different (14N or 15N) media, by MALDI-MS
PMF following protein HPLC and SDS-PAGE protein
separation. In the obtained MALDI-MS spectra, peptides
were present as couples of light (14N) and heavy (15N) ions.
Mass values of the light peptides enable identification by
database searching, whereas the ratio of the intensities of the
light versus the heavy peptides is a read-out for potential
concentration changes of the corresponding yeast protein. In
the same article, differential phosphorylation of a selected
protein, the yeast protein kinase Ste20, was also assessed [2].
Since then, other labs have described similar labeling meth-
ods on various small organisms and cell lines (e.g., Deino-
coccus radiodurans and mouse B16 melanoma cells [3], Ara-
bidopsis thaliana cells [4], and Rhodopseudomonas palustris [5],
see also Section 2.2).
This type of metabolic labeling in cell lines or small
organisms poses high demands on software algorithms for
automated quantification. Amongst others this is because
them/z spacing between light and heavy peptides is not fixed
as is the case for stable isotope labeling by amino acids in cell
culture (SILAC) labeling (see below) but varies depending on
the number of incorporated heavy isotopes. Furthermore, the
used media are never fully composed of the heavy isotopic
variant implying that the proteins are never fully labeled (al-
though typically nearly complete). Hence, the resulting iso-
tope envelopes of the peptide ions differ from the theoreti-
cally calculated and expected ones. This affects recognition of
peptide ions as well as integration of their signals. Finally,
14N and 15N labeled peptides never elute perfectly together
meaning that during LC-MS/MS analysis, retention time
spacing between light and heavy peptides is introduced, fur-
ther complicating retrieval of peptide couples. RelEx [6] and
MSQuant ((http://msquant.sourceforge.net/) and [7]) are
two examples of algorithms that were designed to deal with
these drawbacks and allow automated quantification. How-
ever, from our own experience we learned that such algo-
rithms are often difficult to setup and implement, and always
contain little bugs slowing down the whole process and
making them often not user-friendly.
The lab of Matthias Mann pioneered the use of stable
heavy variants of essential amino acids to metabolically label
proteins in cell cultures (SILAC, [8, 9]). SILAC is a straight-
forward procedure in which natural variants of essential
amino acids are left out of culture media and replaced by
deuterated, carbon-13, and/or nitrogen-15 variants. These
heavy building blocks are readily incorporated into proteins
and typically after a few rounds of cell duplication, pro-
teomes are fully labeled and ready for analysis.
By the combined use of heavy variants of lysine and ar-
ginine – which on average occur at every tenth position in a
protein sequence – and proteome scientist’s favorite protease
trypsin, not surprisingly SILAC is mainly used for quantita-
tive proteomics [9, 10] as well as for pointing to specific pro-
tein binders (e.g., by combining SILAC with RNA inter-
ference (RNAi) mediated knock-down of bait proteins [11]).
Heavy labeled variants of lysine and arginine that provide
ample spacing between isotopic envelopes of light and heavy
tryptic peptides (e.g., 10 Da using 13C6
15N4-Arg and 8 Da
using 13C6
15N2-Lys) are available such that even mass spec-
trometers with low resolving power (for instance ITs) can be
used for quantitative proteomics. Interestingly, since several
forms of lysine and arginine are available, they can be “per-
mutated” and thus allow analysis of three different pro-
teomes (e.g., phosphotyrosine proteomes [12]) or more (up to
5-plexing [13]) at the same time.
It should be kept in mind that metabolic conversion of
arginine to proline can occur and that the arginine isotope
label can thus be “diluted” into heavy proline. Tryptic pep-
tides containing proline will split up into two labeled forms
making data interpretation and quantification more com-
plex. Nevertheless, a labeling approach that makes intelli-
gent use of combinations of lysine and arginine and thereby
introduces an experimental correction for proline conversion
was recently described [14]. Alternatively, algorithm-based
corrections for quantitative proteomics are used [15]. Low-
ering the arginine concentration will also decrease the
degree of arginine to proline conversion, but while this is an
intuitive way of compensating for isotope dilution, we and
other labs observed significant differences in population
doubling rates for several cell lines [16] which might also
point to synthetically introduced and unwanted alterations in
the composition of the labeled proteomes. Thus, ideally, cel-
lular systems that need to be compared are grown in the
same SILAC media (containing dialyzed FCS) and only the
isotopic nature of the label (the essential amino acid that will
be used) and not its concentration differs.
SILAC labeling has been used to study differential pro-
tein phosphorylation (e.g., the yeast pheromone signaling
pathway [15]) and, recently the dynamic interplay betweenO-
GlcNAc modification and glycogen synthase kinase-3 medi-
ated phosphorylation was mapped on a proteome-wide scale
[17].
Having several essential amino acids available (e.g., argi-
nine, lysine, tyrosine, and methionine), proteome studies
targeting a very specific aspect of dynamic proteomes are
now possible. Selected examples of these are discussed in the
following paragraphs.
Our lab introduced the combined fractional diagonal
chromatography (COFRADIC) technique to sort amino (N)
terminal peptides out of digested proteomes [18, 19]. It is
essential here to introduce a difference between protein N-
terminal peptides and other (internal) peptides so that both
types can be distinguished in a diagonal RP-chromato-
graphic setup. This difference is in fact introduced by in vitro
acetylating all free primary protein amines (a and e) prior to
digestion with trypsin. Since, trypsin cannot cleave acetylated
lysines, it acts as endoproteinase Arg-C and generates pep-
tides ending on arginine. Thus, because of these sample
preparation steps, eventually every sorted N-terminal peptide
ends on an arginine and hence arginine SILAC labeling is a
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straightforward way to distinguish the same N-terminal
peptides in different proteomes. A key application of the N-
terminal COFRADIC technique is protease substrate map-
ping, also known as protease degradomics [20]. Protein
cleavage creates a new N-terminal end and the correspond-
ing N-terminal peptide will also be selected by the sorting
procedure. To distinguish real protein N-terminal peptides
from newly formed ones, differential Arg-SILAC labeling is
used. For example, “light” (natural) Arg is incorporated in a
proteome that will be affected by activated proteases, while
“heavy” Arg is incorporated in a control proteome. After
mixing and N-terminal peptide sorting, doublet isotopic
envelopes point to peptides present in both samples, while
singletons are derived from the protease degraded sample.
The latter can then be selected for fragmentation, revealing
not only the identity of the cleaved protein, but also the exact
position of the cleavage site in this protein.
A recent study on taxol-induced cell death of human
nonsmall-cell lung carcinoma A549 cells illustrates our pro-
tease degradome approach. The proteome of dying cells
(12C6-Arg labeled) was compared with that of nontreated cells
(13C6-Arg labeled) using N-terminal peptide sorting [21].
Several in vivo protein processing events were characterized
pointing to both caspases and calpains as being key proteases
activated in this cell death model. As an example, processing
of human plectin-1 (Swiss-Prot accession number Q15149)
after Asp-2771 in taxol-treated A549 cells is shown in Fig. 1
(the corresponding spectra have been generated with a
Waters Q-TOF Premier mass spectrometer (for details see
[21])).
Figure 1. Processing of plectin-1 in taxol-mediated apoptotic A549 cells. Control cells were grown in 13C6-Arg SILAC medium while taxol-
treated (dying cells) were grown in 12C6-Arg SILACmedium. Equal volumes of both cell cultures were mixed and N-terminal peptides were
isolated by COFRADIC. LC-MS/MS analyses were performed on a Waters Q-TOF Premier mass spectrometer (for experimental details, see
[21]). Two doubly charged peptide ions spaced by 3 Th are shown in the top left mass spectrum. These ions are present in about equal
numbers and as expected point to a nonaffected, mature protein N-terminus upon MS/MS analysis; the N-terminus of the vesicle-asso-
ciated membrane protein 3 (VAMP-3, Q15836; the peptide was identified as STGPTAATGSNR (acetylated at its a-amino group)). Shown in
the top right panel is a doubly charged peptide ion that was only present in one sample and was thus expected to originate from in vivo
protein processing in dying A549 cells. Following MS/MS analysis (the deconvoluted spectrum is shown in the bottom panel; only b and y
fragment ions and the precursor ion are indicated) and MASCOT database searching [70], this peptide was identified as GPAAEAE-
PEHSFDGLR (a-amino group acetylated and peptide ending on 12C6-Arg) starting at position 2772 in plectin-1. Since this peptide is pre-
ceded by DALD, this novel N-terminus most probably pointed to hitherto unreported caspase cleavage of plectin-1 at Asp-2771.
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Methionine is an essential and relatively rare amino acid
in mammalian cells (about 2.41% of all amino acids). Pro-
teins can be labeled with heavy variants of Met without risk-
ing isotope dilution into other amino acids using cell culture
protocols that have been established since many years for
35S-Met protein labeling (e.g., [22]). Only for post-translation-
ally methylated proteins there is a transfer of the 13C-methyl
group from methionine via the activated methyl pathway
(see below). Methionyl peptides can be easily isolated using a
simple COFRADIC sorting protocol based on oxidation to
the more hydrophilic sulfoxide form [23]. Because methio-
nine appears in nearly all eukaryotic proteins at low fre-
quency, targeted isolation of methionyl peptides strongly
reduces the overall peptide complexity, while this selection is
just focused on those peptides carrying the differential
quantitative information. Figure 2 shows MS spectra of two
mouse transgelin tryptic peptides carrying either heavy or
light methionine. This actin-associated protein was found
highly induced in mouse embryonic fibroblasts (MEF) cell
lines in which an actin gene was knocked-out (unpublished
results).
A similar sorting protocol can be used for global analysis
of in vivo methionine oxidation as the result of cellular oxi-
dative stress. This protein modification can be considered as
a fundamental sensor of oxygen and oxygen-derived compo-
nents (such as H2O2) in the cell. Like the phosphorylation/
dephosphorylation switch, methionine sulfoxide formation
can lead to conformational changes in targeted proteins,
which may affect their function or downstream signaling,
while sulfoxide formation can be reversed by the action of
cellular reductases. Global analysis of the methionine oxida-
tion status in cells is difficult because of lack of suitable tools
(e.g., modification-specific antibodies). However, if methio-
nines are in vivo oxidized, peptides carrying them will no
longer be affected by the hydrogen peroxide treatment in our
COFRADIC setup and are thus not sorted. We exploited this
in an in vitro cell model of oxidative burst; human Jurkat T-
lymphocytes treated with hydrogen peroxide. These cells
were SILAC labeled with either 12C5
14N-methionine or
13C5
15N-methionine and in a typical experiment, one cell
culture was treated with 3 mM (final concentration following
an initial stimulus with 1 mM) of H2O2 for 2 h, whereas the
Figure 2. Induction of mouse transgelin expression in b-actin knock-out MEF cells. Proteins were labeled by methionine SILAC (wild type
MEFs were grown in 12C514N-Met medium, b-actin knock-out MEFs in 13C515N-Met medium). MS spectra shown here are from different
proteome screens (here denoted experiments 1 and 2) in which methionine COFRADIC was used to compare protein expression levels
between wild type MEFs and two b-actin knock-out MEF cell lines (top and bottom spectra, respectively). Following MS/MS analysis, the
peptide ion in the left MS spectra was identified as 184-GASQAGMoxTGYGR-195 (Mox = methionine-sulfoxide), whereas that in the rightMS
spectra was identified as 90-QMoxEQVAQFLK-99 (N-terminal pyroglutamic acid), both belonging to the mouse transgelin protein (Swiss-
Prot accession number: P37804). The light/heavy ion intensity ratios point to significant induction of expression of this protein in b-actin
knock-out MEF cells (on average more than six-fold). Furthermore, these expression levels differences are very similar for the different
peptides identified (compare left to right spectra) and in different b-actin knock-out MEF cell lines (compare top to bottom spectra). Also
note that the small peak in front of the monoisotopic ion of the heavy labeled peptide (here labeled with an asterisk), is due to the activated
methyl cycle in which the end-standing methyl group of methionine participates. Here, the 13 C-methyl group is gradually replaced by 12 C-
methyl derived from other cellular components. This effect is more pronounced in MEFs compared to other cell lines.
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other cell culture was untreated and served as a control.
Methionine oxidation is a limited and specific modification
as evident from the majority of sorted methionyl peptides
that appeared as couples spaced by 6 Da and showing no
altered concentrations. However, several peptides were pres-
ent at reduced levels in the proteome digest of Jurkat cells
under H2O2 stress and thus pointed to in vivo oxidation, al-
though at this stage increased protein turnover in these cells
cannot be ruled out. An example of a sorted peptide holding
a potential in vivo oxidized methionine in b-filamin is shown
in Fig. 3.
A final example of the potential of SILAC is the analysis
of in vivo methylation by so-called “methyl SILAC” in which
advantage is taken from the fact that methionine is metabo-
lically converted into S-adenosyl methionine (SAM), which is
the most important biological methyl donor. More specifi-
cally, 13CD3-methionine was used as labeling reagent which
is in vivo converted to 13CD3-SAM and thus serves as a heavy
methyl donor. Quantitative proteomics led to the identifica-
tion of 59 in vivo methylation sites, several of which were
hitherto unknown [24].
2.2 Labeling of higher eukaryotes for quantitative
proteomics
Some successful proof-of-concept studies in which entire
higher eukaryotic organisms were metabolically labeled for
quantitative proteomics have been described.
In 2003, the lab of Albert Heck described nitrogen-15
labeling of two small organisms: the nematodeCaenorhabditis
elegans and the fruit flyDrosophila melanogaster [25].C. elegans
was fed on 15N-labeled Escherichia coli and fruit fly larvae were
fed on 15N-labeled yeast. For both organisms 15N labeling was
reported to be 95% or more complete. A quantitative pro-
teome study was done by comparing the early adult stage
proteomes of wild type versus glp-4 mutant (15N-labeled) C.
elegans strains. Since, labeling was done on the level of the
organism, equal numbers of both strains were mixed prior to
proteome isolation thereby reducing downstream experi-
mental errors. Isolated proteomes were then separated by 2D-
PAGE and spots were randomly selected for protein identifi-
cation and quantification. Several proteins were found in
deviating ratios and some were further validated [25].
Figure 3. Methionine-1766 of b-filamin is susceptible to hydrogen peroxide stress in human Jurkat cells. Human Jurkat T-cells were cul-
tured in either light 12C5
14N-Met SILAC medium (control cells) or heavy 13C5
15N-Met SILAC medium (H2O2 treated). Following induction of
oxidative stress (see text), cells were mixed and the extracted proteome was sampled by the methionine COFRADIC technique [23]. An
example of a sorted peptide carrying an in vivo oxidized methionine is shown. The mass spectrum in the inset shows a triply charged
precursor ion which is much more abundant in nontreated cells (more than eight times; compare the signal at 495.87 Th with that at
497.92 Th). Following MS/MS analysis (ESI Q-TOF Premier) of the ion at 495.87 Th (MS/MS spectrum shown; only b and y fragment ions
indicated) and MASCOT database searching, this peptide was identified as 1757-KGEITGEVHMPSGK-1770 with Met-1766 oxidized (to its
sulfoxide) of human b-filamin (O75369), an actin-binding protein.
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Metabolic labeling of a rat by feeding a protein-free diet
supplemented with 15N-enriched algae was described in 2004
by the lab of John Yates [26]. The 15N-labeled liver proteome
of this rat was used as an internal standard to which the
unlabeled liver proteomes of a control rat and a rat treated
with cycloheximide (CHX) were compared by multi-
dimensional protein identification technology (MudPIT),
[27]. The levels of about 1000 different proteins were meas-
ured and 310 of these were quantified in both liver pro-
teomes. Taking advantage of the 15N-liver proteome as an
internal standard, the levels of these 310 proteins in control
liver versus CHX-treated liver were directly determined and
following statistical analysis, 127 proteins with significantly
(p,0.05) different ratios were identified, most of these func-
tioning in xenobiotic metabolism and protein folding.
3 Postmetabolic labeling approaches
3.1 Enzymatic oxygen-18 labeling of peptides
Incorporation of oxygen-18 at the COOH-terminus of pep-
tides during protease mediated-cleavage is known for a long
time [28]. It has been used for MS/MS analysis to help dis-
tinguishing y-ions from b-ions formed by peptide fragmen-
tation (e.g., when digesting proteins in H2
16O/H2
18O (1:1) [29,
30]). An interesting aspect is that the 18O-isotopes are not
only added during proteolysis, but can also be incorporated
postcleavage [31]. Here, proteins are first digested in normal
conditions and only after drying the peptide mixture, H2
18O
is added. Trypsin is here the preferred protease because it
efficiently catalyses the exchange of the two C-terminal oxy-
gen atoms of peptides ending on lysine or arginine, with a
preference for the latter. Thereby, a mass increase in 4 Da is
introduced which is generally sufficient to separate the light
and heavy peptide isotope envelopes, opening this method
for quantitative analysis.
Although the procedure appears as an ideal postcleavage,
stable isotope labeling procedure – it is simple, there is no
need to remove by-products and it is quite cheap since only
small volumes of H2
18O are used – its popularity is limited.
There are probably several reasons for this. First, labeling
takes place late in the overall analytical process; thus the two
samples are processed separately during quite a number of
manipulations before being differently labeled and mixed,
introducing several sites for technical variation. Second,
when trypsin is not fully inactivated or removed after 18O-
exchange, trypsin-mediated back-exchange during down-
stream processing in solvents containing natural water
occurs. Importantly, this isotope dilution is also noticed at
acidic pH (from pH 4 to 5 and lower) where trypsin-medi-
ated cleavage of the peptide bond is assumed to be com-
pletely halted. This was often erroneously interpreted as
incomplete or partial labeling since it was assumed that
peptide cleavage and oxygen exchange were identical pro-
cesses, which is not the case. Third, in the absence of trypsin
but at lower pH (e.g., 0.1% TFA as used in conventional RP
solvents), slow back-exchange also occurs, which can be
avoided by working at higher pH (e.g., using ammonium ac-
etate buffering at pH 4.5–5.5). Fourth, we noticed that for
highly acidic peptides, 16O-18O exchange tends to be slow and
incomplete. Fifth, the 4 Da spacing requires mass spectro-
meters with high resolving power (e.g., Q-TOF, Orbitrap, and
FT-ICR mass spectrometers) to segregate the isotopic envel-
opes. This also implies that the popular ITs can generally not
be used for differential proteomics by 18O-labeling. Although
all of this sheds negative light on the technique, trypsin-
mediated 18O-tagging has its value, since most issues listed
above can be easily controlled and its universal character
makes this labeling technique accessible to all types of sam-
ples including body fluids. In addition, intelligent software
tools have been developed that are able to tackle variable and
inefficient 18O-labeling (e.g., [32]).
In order to evaluate the oxygen-18 tagging procedure in
relation to the SILAC approach, we compared two sets of
differentially labeled N-terminal peptides; one from the hu-
man Jurkat T-lymphocyte cell line, the other from the human
myelogenous leukaemia K562 cell line. The sorted N-termi-
nal peptides from both cell lines had the same nature: a-N-
acetylated and carrying a C-terminal arginine. In both cases,
one proteome preparation was labeled with the heavy iso-
tope, whereas the other contained the natural isotope. For
the Jurkat proteome, peptides were labeled by 18O-tagging at
the peptide level, while for the K562 cells two cell cultures
were used, one of which was labeled with 13C6-Arg. In both
samples the intensity ratios of the light versus the heavy
forms of the peptides were calculated and we could merely
notice differences in the distribution patterns of these ratios
(Fig. 4). This shows that oxygen-18 tagging can indeed be
used in a differential quantitative set-up, provided that very
strict conditions (see above) are created and peptide analysis
is done on high-resolution mass spectrometers.
The oxygen-18 labeling “trick” was also used in a
COFRADIC-based phosphoproteome approach [33]. Phos-
phorylated peptides are separated by RP-HPLC in different
fractions and in each of these, dephosphorylation by phos-
phatases is performed. Dephosphorylation produces a
hydrophobic shift of affected peptides but since the phos-
phate group is now lost, it is difficult to ensure that the
chromatographic shift is provoked by dephosphorylation and
not artificial (e.g., following deamidation). To solve this
problem, the sample was split in two and one part was
labeled with 18O and fully dephosphorylated. Then, both
parts were recombined and subjected to COFRADIC phos-
phoproteomics. Since now a phosphopeptide and its
dephosphorylated counterpart elute in distinct fractions,
peptides that shift and appear as 16O-singletons are desig-
nated as true “ex-phosphopeptides”, while those appearing as
a 16O/18O-doublet are nonphosphorylated peptides.
Oxygen-18 labeling has also been used to more accurately
determine sites of N-glycosylation. Here, peptide-N-glycosi-
dase F (PNGaseF) hydrolysis of the N-linked glycan is per-
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Figure 4. Comparison of SILAC arginine labeling and oxygen-18 labeling. Gray bars correspond to couples of 12C6-Arg/13C6-Arg N-terminal
peptides (414 peptides) isolated from human K562 cells, while black bars correspond to Arg-ending N-terminal peptides (988 peptides)
isolated from human Jurkat cells, but now labeled with two 16O or two 18O isotopes (see text). The distribution of the log 2 values of the
ratios of light versus heavy peptides centers around a value of 0 indicating that, as expected, most peptide ions are present in equal
amounts in the sampled proteomes. Furthermore, these distributions are very similar, indicating that 18O-labeling can be as accurate as
SILAC labeling for quantitative proteomics.
formed in H2
18O by which a mass tag of 3 Da compared to
the mass of peptide stored in databases appears following
MS (e.g., [34, 35]).
3.2 Nonenzymatic labeling methods
3.2.1 Isotope labeling of amino groups at the peptide
level
Primary amines are favorite targets for isotope labeling be-
cause of their specific reactivity and the wide variety of avail-
able reagents. Rather simple labeling protocols make use of
acetylation or acylation of amino groups for quantitative
proteomics. For example, mass differences of 3 Da (e.g., by
trideutero-acetylation [36] or 13C-propionylation) or 4 Da (e.g.,
by succinylation [37]) can be introduced. Reductive dimethy-
lation also yields a mass increase in 4 Da when deuterated
formaldehyde is used [38]. Here, the tertiary amine created at
the peptide’s N-terminus is suggested to enhance a1-frag-
ment ion formation, thereby improving database searching
[39]. More recently, it was shown that combinations of the
used reagents – d0 and d2 formaldehyde and d0 or d3
sodium cyanoborohydride – allow simultaneous analysis of
four different proteome samples [40]. Interestingly, the
authors reported negligible shifts in RP-column retention
times, which is generally a problem when deuterium is used
for the creation of heavy mass tags (see the original isotope-
coded affinity tag (ICAT) molecules). Because these reagents
generally do not distinguish between a- and e-amino groups,
mass tagging depends on the number of lysines present in
the modified peptide. This can create problems at two levels:
nonuniform mass tagging and risk of variable chromato-
graphic effects. However, this can be controlled when
digesting proteins with endoproteinase-Lys-C yielding pep-
tides which have in general only one C-terminal lysine.
3.2.2 Isotope labeling of amino groups at the protein
level
Amino mass tagging can also be performed at the protein
level. This creates the flexibility to either preprotect e-NH2-
lysine groups (e.g., by guanidination) or not, thereby steering
the tagging either exclusively to protein N-termini or to both
a-and e-amino groups.
N-terminal nicotinylation was introduced by the lab of
Peter James in 2000 [41] and became later commercialized as
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ICPL (isotope-coded protein labeling [42]). Using combina-
tions of d0, d4, and 13C5 nicotinic acid N-hydroxysuccinimide
(NHS)-esters, multiplexed differential analysis became pos-
sible. When only present at the a-amino group of modified
peptides, the fixed positive charge of the label at acidic pH
directs peptide fragmentation and, by increasing the signals
of b-type of fragment ions, can be used for de novo sequence
analysis. In a follow-up of this chemistry, James’s lab intro-
duced the parent (precursor) ion quantitation scanning
(PIQS) technology [43]. The general idea is here to only
sample peptides that show significant deviating levels for
MS/MS analysis. In brief, this is achieved as follows. All
protein lysines are blocked by succinylation to prevent them
from further reaction. Following digestion, peptides are
reacted with iodoacetic anhydride making their N-termini
reactive for the PIQS reagents (e.g., different isotopic forms
of mercaptobenzimidazoles). In LC-MS/MS mode, mass
spectrometers alternatively scan for the light and heavy sig-
nature ions from the PIQS reagents (parent ion scans), track
such pairs and calculate their ratios. Subsequently, only pep-
tides with a significantly altered ratio are analyzed in full MS/
MS mode and identified. This approach seemingly holds
great potential for future, more rational, and intelligent dif-
ferential proteome studies.
We recently showed that our N-terminal COFRADIC
technique can be used to assess the in vivo acetylation status
of protein a-N-termini [18] and thus characterize the general
substrate specificities of the a-N-acetyltransferase complexes
that cotranslationally acetylate nascent polypeptide chains.
In higher eukaryotes, the majority of cytosolic proteins are
expected to be acetylated at their a-N-terminus however by
lack of analytical tools no real systematic analysis has been
performed. Prior to the actual COFRADIC steps, all free
amino groups of proteins need to be blocked to allow the
largest recovery of N-terminal peptides. This is most con-
veniently done with an NHS-ester of acetate [19]. Upon
replacing this reagent with an NHS-ester of trideutero-ace-
tate, a mass tag is incorporated at all in vivo free a-amino
groups and all lysines. Hence, following MS/MS analysis of
COFRADIC-sorted N-terminal peptides, in vivo acetylated
protein N-termini are readily distinguished from in vivo free
N-termini which hold an in vitro trideutero-acetylated a-N-
terminus. Examples of in vivo fully, partially and non-
acetylated protein N-termini are shown in Fig. 5. Besides for
reporting the in vivo modification status of protein N-ter-
mini, we use trideutero-acetyl groups to locate protein pro-
cessing by proteases [44]. As discussed above, when used in a
differential modus (e.g., control vs. apoptotic cells), N-termi-
nal COFRADIC sorts neo-N-termini that report protein pro-
cessing events (see also Fig. 1). Since proteases create protein
breaks, new a-N-termini arise. When these are now chemi-
cally trideutero-acetylated, an additional mass tag is present
in the COFRADIC-sorted peptides that is used to directly
point out potential protein processing events in result lists of
database search engines. Indeed, such reporter peptides start
typically many positions away from the initiator methionine
and are readily distinguished from in vivo acetylated peptides
also starting at such positions but pointing to alternative
translation starts or gene prediction errors.
An interesting alternative for multiplexed quantitative
peptide labeling is offered by the iTRAQ chemistry intro-
duced in 2004 [45]. These amino-reactive reagents are com-
posed of two distinct groups: a balancing group and a
reporter group. While the individual moieties hold a gradual
change in mass, they are assembled such that the sum of the
masses of these two groups is always the same and the
reagents are therefore termed isobaric. During PSD or MS/
MS, the bond linking the balancing group and the reporter
group is broken and the reporter ions are detected in peptide
fragmentation spectra and used to quantify the peptide levels
in each proteome. Besides for protein quantification, iTRAQ
has been used for discovering protease substrates [46, 47].
While the first version of iTRAQ allowed 4-plexed proteome
studies [45], the newest version now allows 8-plexing [48] and
is expected to speed up the throughput of proteomics sig-
nificantly. A similar reagent designed to label proteins rather
than peptides (protein iTRAQ) appears to have a few prob-
lems related to detection of the reporter ions and peptide
identification. One interesting observation was that for mul-
tiple charged precursor ions, high collision energies were
needed for efficient liberation of the iTRAQ reporter ions
from modified lysine side-chains, and this resulted in poor
generation of b and y fragment ions hindering peptide iden-
tification [49].
3.2.3 Labeling of thiol groups
An early example of combining shotgun proteomics and
quantification is the ICATmethod developed by the group of
Aebersold [50]. Originally, a modified thiol-reactive iodoacet-
amide derivative harboring an affinity tag (biotin) and a linker
region was used to modify cysteines such that following pro-
tein digestion, cysteinyl peptides could be affinity-isolated for
further analysis. Since cysteine is rare amino acid (making up
1.42% of all amino acids), the ICAT approach significantly
reduces the sample complexity. The linker region could carry
up to 8 deuteriums (d8 ICAT) thus providing sufficient m/z
spacing in mass spectra and allowing quantitative proteom-
ics. It was however reported that the d0 and d8 ICAT tagged
peptides had different retention on RP columns: d8 ICAT
tagged peptides are less well retained and elute in front of d0
ICAT tagged peptides [51, 52]. If this is not postanalytically
corrected, erroneous peptide ratios will be determined. Fur-
thermore, the original ICATtag is very bulky andwas reported
to pose problemswhen interpretingMS/MS spectra of tagged
peptides sincemany fragment ions resulted from the tag itself
rather than from the actual peptide backbone [53]. More
recent,MS/MS fragmentation hindrances were compensated
by the introduction of solid-phase tags with cleavable linkers
[54] that were further labeled with carbon-13 instead of deu-
terium by which coelution between light and heavy peptides
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Figure 5. MS and MS/MS spectra pointing to in vivo free and acetylated protein a-N-termini. MS and MS/MS spectra of doubly charged
peptide ions are shown at the left and right sides, respectively. Spectra shown in the upper panel originate from an in vivo acetylated (Ac) a-
N-terminus from the Shwachman-Bodian-Diamond syndrome protein (Q9Y3A5). The peptide was identified as 2-SIFTPTNQIR-12, with its
N-terminus acetylated. Spectra in the middle panel point to the presence of two variants (i.e., the a-N-acetylated and free (AcD3) forms) of
the N-terminus of the zuotin-related factor 1 (Q99543). Here, the trideutero-acetylated peptide ion was sampled byMS/MS and identified as
2-MLLLPSAADGR-12 (its methionine was oxidized to a sulfoxide). Spectra shown in the lower panel point to an in vivo free a-N-terminus
(peptide identified as 2-PMFIVNTNVPR-12 with its N-terminus in vitro trideutero-acetylated and the methionine oxidized) from the macro-
phage migration inhibitory factor (P14174). In all MS/MS spectra, the m/z-values of the b-type of fragment ions are indicated as are the
observed y-fragment ions.
was accomplished [55]. An interesting application of the
ICAT technology is the characterization of oxidation-sensi-
tive, protein-bound cysteines (redox proteomics) [56]. The
assumption here is that in conditions of oxidative stress
some cysteine thiol groups get modified such that these are
no longer open to ICAT modification. Upon comparing a
control cell population with one under oxidative stress,
ICAT-tagged peptide couples showing altered ratios may
point to in vivo modified cysteines [56]. ICAT labeling has
also been used to study protein processing by matrix
metalloproteases (e.g., [57, 58]). Here, the levels of secreted
and shed extracellular proteins are quantified by ICATusing
cell lines that typically over-express the metalloprotease of
interest.
4 Methods for absolute quantification
Rather simple absolute quantification was introduced by the
group of Steven Gygi in 2003 [59]. The absolute quantifica-
tion of proteins (AQUA) technology makes uses of heavy
isotope labeled peptides as internal standards added pre-
ferentially as early as possible in the analytical process. More
multiplexed absolute quantification was done by first con-
structing a nonnatural gene in which the different tryptic
peptides one wants to quantify are concatenated. This
patchwork protein is expressed in a host cell system for pro-
ducing recombinant proteins such as E. coli grown in nitro-
gen-15 media (thus labeling the recombinant protein). By
use of affinity tags, the protein is isolated and, following
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digestion with trypsin, a set of heavy labeled signature pep-
tides – typically, these are peptides known to ionize well and
their sequences are derived from the proteins one wants to
quantify – that can be used as internal standards for prote-
omics is in that way created [60]. In follow-up studies, these
so-called QconCAT peptides (or concatamers of quantitative
(Q) peptides) were produced in 13C6-Lys and
13C6-Arg media
instead of 15N media [61, 62]. Now, all QconCAT peptides
hold the same mass difference (6 Da) compared to their nat-
ural counterparts, making quantification more straightfor-
ward.
A very important issue relates to the actual peptide that
will be selected as an internal standard. When starting from
predictions only, these peptides should be well soluble
allowing their isolation following production, easily ionized
and only point to a single protein (or protein isoform) in the
complex background of a complete proteome. Production
problems of QconCAT peptides were recently reported [63]
and illustrate the necessity of selecting peptides based on
experimental data next to plain predictions. Ideally, proteo-
typic peptides [64, 65] – peptides that are observable by mass
spectrometers (thus ionize and fragment well and with m/z-
values well inside the practical m/z-range of the spectrome-
ter used) and can be unambiguously associated to a single
protein – should be selected and analyzed by targeted multi-
ple reaction monitoring (MRM) (e.g., [66]).
Despite the different solutions proposed for absolute
protein quantification, the challenge in this field remains
considerable and there are several important issues requir-
ing reflection. In a direct differential comparison (relative
quantification), the variables in the two samples are in a
physical and chemical identical state, the only differences
being their concentrations and their masses. By for instance
combining two proteome samples early in a SILAC prote-
omics schema, all consecutive losses encountered in the fol-
lowing steps will be identical for the two protein (and later on
peptide) isotopic variants. Thus, onemay logically expect that
the peptide ratios will correctly reflect the ratios of their par-
ent proteins. The same reasoning will hold for an absolute
quantification strategy if the protein to be measured is com-
pared to the same protein generated as an isotope variant
added at the beginning of the entire process. Unfortunately,
while this might be possible for one or a few proteins (for
which each time an isotopic variant has to be generated, pu-
rified, and exactly quantified) such strategy cannot be fol-
lowed for screens of tens or hundreds of proteins simulta-
neously. Therefore, peptides have been suggested as pre-
ferred “standard compounds” to measure the concentrations
of their naturally occurring parent proteins. Peptides are
readily synthesized, purified, and quantified in large quan-
tities and further tagged with a large variety of 13C- or 15N-
labeled derivatives, not only restricted anymore to the essen-
tial amino acids.
This is fine when the standard is added in an appropriate
amount to the biological sample immediately before (as a
concatenated artificial protein) or after (as individual pep-
tides) the proteolytic cleavage process and when the gener-
ated peptide mixture can be directly injected in the mass
spectrometer for analysis. Unfortunately, the complexity of
biological samples is generally too high such that preproces-
sing is necessary. This can for instance be depletion of the
most abundant serum/plasma proteins, protein precipita-
tion, prefractionation, protein modification such cysteine
side-chain stabilization, etc.. It is clear that reference peptides
can only be added at later stages, which means that the
quantification will not include the variable and unpredictable
individual protein losses that may be encountered in all pre-
processing steps. Taking these limitations into account, the
peptide reference approach would still remain valuable when
the preprocessing steps are standardized and carried out in a
highly reproducible manner.
5 Conclusions
Tagging proteins or peptides with stable heavy isotopes has
found broad applications in contemporary proteomics,
which is relying on MS as the analytical instrument. Gen-
erally, heavy isotopes of hydrogen (D), carbon (13C), nitrogen
(15N), and oxygen (18O) are used. Although the choice of iso-
topes is often connected to the proteomic question and sam-
ple to be analyzed, major selection criteria are determined by
the mass difference produced upon isotope labeling and the
extent of the potential shift that is produced during chro-
matographic separation of the normal and heavy peptide
variants. As a general rule, mass differences should pre-
ferably not be less than 4 Da, since too much overlap be-
tween the isotopic envelopes of the light and heavy variants
will occur. When the two variants are at less than 4 Da
mathematical corrections are necessary taking into account
natural isotope distribution, mass and/or sequence of the
peptides [32]. It is now generally accepted that natural pep-
tides and their heavy isotope variants may elute differently
during RP-HPLC (depending on the elution system). Deut-
erated components are frequently reported to be more sen-
sitive to such chromatographic effects in particular when the
deuterium is bound to a sp3 carbon (e.g., as in the original d8
ICATmolecule, see above). Other isotopes – 13C, 15N, and 18O
that are amongst others present in different SILAC amino
acids as well as in iTRAQ reagents – appear much less sen-
sitive and are therefore preferred above deuterium.
In this paper, we illustrated different uses of stable heavy
isotope labeling. The most direct applications are differential
quantitative analyses, where two or more samples are differ-
ently tagged, mixed in equal amounts, and simultaneously
analyzed. While all isotopic variants are assumed to behave
in an identical manner during consecutive purification steps,
the resolution and quantification of the different isotopic
variants is left to the mass spectrometer. In this situation, it is
of high importance to incorporate mass tags as high
upstream as possible in the entire process. This is most con-
veniently done using a SILAC-type of approach. If impos-
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sible, tagging either at the protein or even lower, at the pep-
tide level, is performed. Here, it is realized that introducing
the isotope tags downstream the process may increase the
risk for uncontrollable variations in the different samples. In
most cases, two different proteome samples are compared,
however more complex labeling strategies allow multi-
plexing as described above for SILAC and iTRAQ.
As described herein, heavy isotopes can also be used to
direct proteomics to the peptides of interest. Indeed, peptide-
centric proteomics generally deals with an extremely high
number of different compounds that cannot be fully covered
even with the best mass spectrometers [67]. Therefore, strat-
egies have been developed to either reduce the complexity or
to target the peptides of interest. Very often, one can use iso-
tope tagging to discriminate targeted peptides. From our
own work we have shown examples where peptides report-
ing a proteolytic cleavage site (e.g., due to activity of apoptotic
proteases) can be distinguished from normal protein N-ter-
mini (e.g., [21, 68, 69]). Similarly, we have used the doublet-
versus-singleton approach to identify and confirm phospho-
peptides [33]. Differential acetylation/trideutero-acetylation
allows distinguishing in vivo a-N-acetylated from nonblocked
proteins [18]. Finally, we have been able to characterize in
vivo methionine oxidation during oxidative stress. In each of
these examples a different isotope tagging method was used:
18O-16O exchange, arginine SILAC, trideutero-acetylation
and methionine SILAC, illustrating the possibilities of a tool
that makes proteomics more versatile and more selective.
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